Omega Healthcare Investors (NYSE:OHI) Earns Overweight Rating from Wells Fargo & Company

Wells Fargo & Company reaffirmed their overweight rating on shares of Omega Healthcare Investors (NYSE:OHI) in a report released on Tuesday morning, Benzinga reports. They currently have a $43.00 target price on the real estate investment trust’s stock, up from their previous target price of $40.00.

A number of other research firms also recently issued reports on OHI. Mizuho downgraded shares of Omega Healthcare Investors from an outperform rating to a neutral rating and boosted their target price for the company from $34.00 to $35.00 in a research report on Thursday, July 25th. Scotiabank boosted their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a sector perform rating in a report on Monday, August 26th. Finally, Truist Financial raised their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a hold rating in a report on Wednesday, September 4th. Seven analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, Omega Healthcare Investors has an average rating of Hold and a consensus price target of $36.00.

Omega Healthcare Investors Price Performance

Shares of OHI opened at $39.34 on Tuesday. The company has a 50 day moving average of $39.10 and a two-hundred day moving average of $34.61. The company has a quick ratio of 5.79, a current ratio of 5.79 and a debt-to-equity ratio of 1.19. Omega Healthcare Investors has a twelve month low of $27.53 and a twelve month high of $41.53. The company has a market cap of $9.72 billion, a price-to-earnings ratio of 35.44, a price-to-earnings-growth ratio of 1.30 and a beta of 1.00.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The business had revenue of $252.70 million during the quarter, compared to analyst estimates of $205.92 million. During the same period in the previous year, the business earned $0.74 EPS. The firm’s revenue for the quarter was up 17.5% compared to the same quarter last year. As a group, analysts predict that Omega Healthcare Investors will post 2.69 earnings per share for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Monday, August 5th were given a $0.67 dividend. The ex-dividend date was Monday, August 5th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.81%. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 241.44%.

Insiders Place Their Bets

In related news, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company’s stock.

Institutional Investors Weigh In On Omega Healthcare Investors

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Versant Capital Management Inc purchased a new position in shares of Omega Healthcare Investors during the 2nd quarter worth $26,000. WFA Asset Management Corp purchased a new position in Omega Healthcare Investors during the 1st quarter valued at about $39,000. Covestor Ltd raised its stake in shares of Omega Healthcare Investors by 47.6% in the first quarter. Covestor Ltd now owns 1,337 shares of the real estate investment trust’s stock valued at $42,000 after acquiring an additional 431 shares in the last quarter. Highlander Capital Management LLC raised its holdings in Omega Healthcare Investors by 52.0% in the first quarter. Highlander Capital Management LLC now owns 1,900 shares of the real estate investment trust’s stock valued at $60,000 after acquiring an additional 650 shares in the last quarter. Finally, GAMMA Investing LLC lifted its stake in Omega Healthcare Investors by 93.4% in the second quarter. GAMMA Investing LLC now owns 2,446 shares of the real estate investment trust’s stock worth $84,000 after acquiring an additional 1,181 shares during the last quarter. Hedge funds and other institutional investors own 65.25% of the company’s stock.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.